AER 1613878 is a spontaneous case, received on 27/Jul/2015 from an other health care professional via Health 
Canada (MHPD) reference number: E2B00291929 and concerns a 58 year old female patient  who developed 
apathy, aphasia, fatigue, jc virus infection, neurological decompensation and progressive multifocal 
leukoencephalopathy while being treated with mycophenolate mofetil, belimumab and prednisone.
The patient's concomitant medications included hydroxychloroquine sulfate. Her medical history, past drugs or 
concurrent conditions were not reported.
On an unknown date, the patient started therapy with mycophenolate mofetil 1500 mg, twice daily (route and form 
not reported), belimumab (route, dose, form  and frequency not reported) and prednisone 10 mg (route, form and 
frequency not reported) for systemic lupus erythematosus. Later, she developed apathy, aphasia, fatigue, jc virus 
infection, neurological decompensation and progressive multifocal leukoencephalopathy. It was not confirmed if the
suspect drug mycophenolate mofetil was a roche product.
At the time of this report, events apathy, aphasia, fatigue, jc virus infection, neurological decompensation and 
progressive multifocal leukoencephalopathy were persisting. Therapy ongoing status with mycophenolate mofetil, 
belimumab and prednisone was not reported.
The reporter assessed events apathy, aphasia, fatigue, jc virus infection, neurological decompensation and 
progressive multifocal leukoencephalopathy as medically significant.
The reporter did not report causality of apathy, aphasia, fatigue, jc virus infection, neurological decompensation and
progressive multifocal leukoencephalopathy with mycophenolate mofetil, belimumab and prednisone.
No further information was provided.